novo nordisk glp-1 receptor agonist weight management diabetes treatments Drops Hims & Hers: Inside the Compounded Crisis Ozempic's patent problem: how Novo
Description
For GLP-1s specifically, because they tend to have such an outsize impact on prescription spending, its a good idea to have a pharmacist assist in evaluating them
The literature indicates potential interactions between some disclosed ingredients and certain medications, particularly berberine with diabetes and blood pressure medications
Mu Y, Gage FH
Reducing food intake and extending satiety are significant for weight management and loss
Switching between GLP1RAs should be individualised to mitigate known adverse effects, in particular, those gastrointestinal in nature
